Pfizer Lipitor, Detrol Removed From Florida Medicaid Preferred Drug List
Executive Summary
Florida Medicaid recipients will have to try at least two other drugs in the same category before they are allowed to receive any of six Pfizer drugs recently removed from the state's preferred drug list
You may also be interested in...
After Early Blow, Pfizer Prepares For Round Two Of Lipitor/Generic Zocor Fight
Although Lipitor has taken a beating in the run up to the launch of generics of Merck's Zocor, Pfizer is gearing up for a second round of movement in the cholesterol market, during which patients inadequately controlled on generic statins will switch to Lipitor, Pfizer CEO Hank McKinnell said June 13
After Early Blow, Pfizer Prepares For Round Two Of Lipitor/Generic Zocor Fight
Although Lipitor has taken a beating in the run up to the launch of generics of Merck's Zocor, Pfizer is gearing up for a second round of movement in the cholesterol market, during which patients inadequately controlled on generic statins will switch to Lipitor, Pfizer CEO Hank McKinnell said June 13
Merck Wins Part D Cholesterol Therapy Formulary Battle; Lipitor In Retreat?
Merck appears to be the big winner in the Medicare Part D formulary placement battle for cholesterol-lowering therapies, according to an analysis of plan formularies conducted by the "The Pink Sheet."